← back to search

Rebecca G. Clifton

George Washington University · US
Area of research
Obstetrics and Gynecology · Neurology
Research interest
Research interests include Pregnancy and preeclampsia studies, Gestational Diabetes Research and Management, COVID-19 Impact on Reproduction, and Long-Term Effects of COVID-19.
h-index
28
citations
4,290
works
100
NIH funding
primary concept
Medicine
email

Recent publications

Intrauterine SARS-CoV-2 Exposure and Infant Neurodevelopment through 18 Months of Age: Findings from the Researching COVID to Enhance Recovery (RECOVER) Pregnancy Study
The Journal of Pediatrics 2026cited by 2position: middledoi
Sex Differences in Long COVID
JAMA Network Open 2025cited by 82position: middledoi
The association of cytomegalovirus hyperimmune globulin with adverse pregnancy outcomes
American Journal of Obstetrics and Gynecology 2025cited by 2position: middledoi
Neurodevelopmental Outcomes After Late Preterm Antenatal Corticosteroids
JAMA 2024cited by 56position: middledoi
Researching COVID to enhance recovery (RECOVER) pediatric study protocol: Rationale, objectives and design
PLoS ONE 2024cited by 16position: middledoi
Post–Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) After Infection During Pregnancy
Obstetrics and Gynecology 2024cited by 13position: middledoi
Comparative effectiveness trial of metformin versus insulin for the treatment of gestational diabetes in the USA: clinical trial protocol for the multicentre DECIDE study
BMJ Open 2024cited by 5position: middledoi
LB01 Development of post-acute sequelae of SARS-CoV-2 (PASC) after infection in pregnancy: NIH RECOVER-Pregnancy Cohort
American Journal of Obstetrics and Gynecology 2024cited by 0position: middledoi
Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: an individual participant data meta-analysis
BMJ Global Health 2023cited by 180position: middledoi
Tranexamic Acid to Prevent Obstetrical Hemorrhage after Cesarean Delivery
New England Journal of Medicine 2023cited by 114position: middledoi
Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design
PLoS ONE 2023cited by 56position: middledoi
Cervical Pessary for Prevention of Preterm Birth in Individuals With a Short Cervix
JAMA 2023cited by 50position: middledoi
Researching COVID to enhance recovery (RECOVER) pregnancy study: Rationale, objectives and design
PLoS ONE 2023cited by 17position: middledoi
Randomized Trial of Hyperimmune Globulin for Congenital CMV Infection — 2-Year Outcomes
New England Journal of Medicine 2023cited by 13position: middledoi
Prediction of vaginal birth after cesarean using information at admission for delivery: a calculator without race or ethnicity
American Journal of Obstetrics and Gynecology 2023cited by 11position: middledoi
Association of SARS-CoV-2 Infection With Serious Maternal Morbidity and Mortality From Obstetric Complications
JAMA 2022cited by 276position: middledoi
Cell-free DNA screening for prenatal detection of 22q11.2 deletion syndrome
American Journal of Obstetrics and Gynecology 2022cited by 72position: middledoi
Cell-free DNA screening for trisomies 21, 18, and 13 in pregnancies at low and high risk for aneuploidy with genetic confirmation
American Journal of Obstetrics and Gynecology 2022cited by 59position: middledoi
First- or second-trimester SARS-CoV-2 infection and subsequent pregnancy outcomes
American Journal of Obstetrics and Gynecology 2022cited by 38position: middledoi
Protocol for a sequential, prospective meta-analysis to describe coronavirus disease 2019 (COVID-19) in the pregnancy and postpartum periods
PLoS ONE 2022cited by 12position: middledoi
A Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus Infection
New England Journal of Medicine 2021cited by 150position: middledoi
Cell-Free Total and Fetal DNA in First Trimester Maternal Serum and Subsequent Development of Preeclampsia
American Journal of Perinatology 2016cited by 27position: middledoi
Adverse Pregnancy Outcomes among Women with Prior Spontaneous or Induced Abortions
American Journal of Perinatology 2013cited by 52position: firstdoi
Maternal Insulin Resistance and Preeclampsia
Obstetric Anesthesia Digest 2012cited by 26position: middledoi

Grants

Gestational hypertension and preeclampsia blood pressure (BP) Treatment goals <140/90 vs. <160/110 mmHg: The GOALPOST Trial
NIH1U01HD114633-01A1$2,011,1512025–2030Contact PIRePORTER
Optimal Dosing of Understudied Drugs Administered to Pregnant Individuals per Standard of Care (PregDose)
NIH1U01HD118959-01$1,669,5962025–2030Contact PIRePORTER
Adjunctive Azithromycin Prophylaxis for Scheduled/Prelabor Cesarean Delivery
NIH1U01HD114634-01$3,614,1402024–2029Contact PIRePORTER
Adjunctive Azithromycin Prophylaxis for Scheduled/Prelabor Cesarean Delivery
NIH5U01HD114634-03$3,364,8332024–2029Contact PIRePORTER
Adjunctive Azithromycin Prophylaxis for Scheduled/Prelabor Cesarean Delivery
NIH5U01HD114634-02$3,341,4942024–2029Contact PIRePORTER
A Dose Escalation Study of Low Dose Aspirin for the Prevention of Recurrent Preterm Birth
NIH5U01HD109332-02$2,789,3442024–2029Contact PIRePORTER
A Dose Escalation Study of Low Dose Aspirin for the Prevention of Recurrent Preterm Birth
NIH1U01HD109332-01A1$2,555,0132024–2029Contact PIRePORTER
A Dose Escalation Study of Low Dose Aspirin for the Prevention of Recurrent Preterm Birth
NIH5U01HD109332-03$2,540,3832024–2029Contact PIRePORTER
Maternal-Neonatal Registry (PAIR) Supplemental Funding
NIH3U24HD036801-27S1$450,0002024–2030Contact PIRePORTER
Prescription After CesareanTrial - (PACT) MFMU Supplement
NIH3U24HD036801-24S1$550,0002021–2022Contact PIRePORTER
2/2: A Randomized Controlled Trial of Pravastatin for the Prevention of Preeclampsia in High Risk Women
NIH5U24HL140168-03$2,175,4342018–2024Contact PIRePORTER
2/2: A Randomized Controlled Trial of Pravastatin for the Prevention of Preeclampsia in High Risk Women
NIH5U24HL140168-02$2,166,1062018–2024PIRePORTER
2/2: A Randomized Controlled Trial of Pravastatin for the Prevention of Preeclampsia in High Risk Women
NIH5U24HL140168-04$1,969,5602018–2024Contact PIRePORTER
2/2: A Randomized Controlled Trial of Pravastatin for the Prevention of Preeclampsia in High Risk Women
NIH1U24HL140168-01$1,091,6972018–2024PIRePORTER
2/2: A Randomized Controlled Trial of Pravastatin for the Prevention of Preeclampsia in High Risk Women
NIH5U24HL140168-06$12018–2025Contact PIRePORTER
2/2: A Randomized Controlled Trial of Pravastatin for the Prevention of Preeclampsia in High Risk Women
NIH5U24HL140168-05$12018–2024Contact PIRePORTER
Pulmonary Complications in a Birth Cohort after a Randomized Trial of Antenatal Corticosteroids: the ALPS Follow-Up Study - Data Coordinating Center (ALPS FS - DCC)
NIH5R01HL098354-07$1,919,8682010–2022Contact PIRePORTER
Pulmonary Complications in a Birth Cohort after a Randomized Trial of Antenatal Corticosteroids: the ALPS Follow-Up Study - Data Coordinating Center (ALPS FS - DCC)
NIH5R01HL098354-08$1,795,1252010–2024Contact PIRePORTER
Prenatal Genetic Diagnosis by Genomic Sequencing: A Prospective Evaluation
NIH5R01HD055651-13$1,861,4642007–2023PIRePORTER
Prenatal Genetic Diagnosis by Genomic Sequencing: A Prospective Evaluation
NIH5R01HD055651-14$1,792,6352007–2023PIRePORTER
Prenatal Genetic Diagnosis by Genomic Sequencing: A Prospective Evaluation
NIH5R01HD055651-15$1,388,5782007–2025PIRePORTER
Prenatal Genetic Diagnosis by Genomic Sequencing: A Prospective Evaluation
NIH2R01HD055651-11$1,228,5462007–2023PIRePORTER
Prenatal Genetic Diagnosis by Genomic Sequencing: A Prospective Evaluation
NIH5R01HD055651-12$1,221,2692007–2023PIRePORTER
Data Coord Ctr-NICHD Cooperative Multicenter Maternal Medicine Units Research Net
NIH5U10HD036801-22$16,219,1111998–2021Contact PIRePORTER
Data Coord Ctr-NICHD Cooperative Multicenter Maternal Medicine Units Research Net
NIH4U10HD036801-21$14,124,7691998–2021Contact PIRePORTER

Frequent collaborators

George R. Saade · Norwegian Womens Public Health Association8 papers (2012–2024)Dwight J. Rouse · The University of Texas at San Antonio7 papers (2021–2025)Alan Tita · University of Alabama at Birmingham7 papers (2021–2025)Torri D. Metz · University of Utah6 papers (2022–2024)George A. Macones · The University of Texas at Austin6 papers (2021–2025)Hyagriv N. Simhan · Michigan State University6 papers (2021–2025)Samuel Parry · MetroHealth Medical Center5 papers (2021–2025)John M. Thorp · University of North Carolina at Chapel Hill5 papers (2012–2024)Geeta K. Swamy · Duke University4 papers (2021–2025)Monica Longo · Ingegneria dei Sistemi (Italy)4 papers (2022–2024)Yasser Y. El‐Sayed · Stanford Medicine4 papers (2021–2025)Maged M. Costantine · MetroHealth Medical Center4 papers (2021–2023)Uma M. Reddy · Columbia University Irving Medical Center4 papers (2016–2023)Brenna L. Hughes · Brown University4 papers (2021–2025)Suneet P. Chauhan · S.P.E.C.I.E.S.4 papers (2021–2023)Michael W. Varner · University of Utah4 papers (2012–2025)Kenneth J. Leveno · University of Alabama at Birmingham3 papers (2012–2016)Yoram Sorokin · Wayne State University3 papers (2012–2016)William A. Grobman · John Brown University3 papers (2022–2023)Susan M. Ramin · University of Alabama at Birmingham3 papers (2012–2016)